Search results for "Brief Psychiatric Rating Scale"

showing 10 items of 15 documents

Brain density in depression: methodological and psychopathological aspects

1988

The relationship between brain density, measured by computerized tomography (CT), and severity of depression was investigated in 44 patients with a major depressive episode according to DSM-III. In order to limit methodological problems, correlations between both the Brief Psychiatric Rating Scale (BPRS) and the Bech-Rafaelsen Melancholia Scale (BRMS) with density values were controlled for age, different ventricle measurements, brain size, and density and size of the skull. The BRMS score correlated inversely with density of the right thalamus, the right head of the caudate, and with parietal grey matter and occipital regions of both hemispheres. Similar, but nonsignificant results, were o…

AdultMalePsychiatric Status Rating Scalesmedicine.medical_specialtyDepressionCaudate nucleusParietal lobeBrainAnatomyGrey matterAudiologyPsychiatry and Mental healthmedicine.anatomical_structureBrief Psychiatric Rating ScaleBrain sizemedicineHumansFemalemedicine.symptomTomography X-Ray ComputedOccipital lobeMajor depressive episodePsychologyDepression (differential diagnoses)Acta Psychiatrica Scandinavica
researchProduct

Increased amygdala and parahippocampal gyrus activation in schizophrenic patients with auditory hallucinations: An fMRI study using independent compo…

2010

Objective: Hallucinations in patients with schizophrenia have strong emotional connotations. Functional neuroimaging techniques have been widely used to study brain activity in patients with schizophrenia with hallucinations or emotional impairments. However, few of these Studies have investigated the association between hallucinations and emotional dysfunctions using an emotional auditory paradigm. Independent component analysis (ICA) is an analysis method that is especially useful for decomposing activation during complex cognitive tasks in which multiple operations occur simultaneously. Our aim in this Study is to analyze brain activation after the presentation of emotional auditory stim…

AdultMalePsychosisFACIAL EXPRESSIONSHallucinationsBrain activity and meditationDIFFERENTIAL NEURAL RESPONSENEUROBIOLOGYFEARFUL FACESIndependent component analysisAuditory hallucinationsAmygdalaSeverity of Illness IndexPSYCHOSISFunctional neuroimagingBrief Psychiatric Rating ScalemedicineEMOTIONHumansBRAINBiological PsychiatryAuditory hallucinationSALIENCEmedicine.diagnostic_testABNORMALITIESfMRIRECOGNITIONmedicine.diseaseAmygdalaMagnetic Resonance ImagingAuditory emotional paradigmPsychiatry and Mental healthmedicine.anatomical_structureSchizophreniaParahippocampal Gyrusmedicine.symptomPsychologyFunctional magnetic resonance imagingBrain activityNeuroscienceParahippocampal gyrus
researchProduct

Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia

2008

Abstract Objective Previous studies have found neurochemical abnormalities in thalamic nuclei in patients with schizophrenia. These abnormalities have been associated with information processing deficiencies and symptom formation. There are no metabolic spectroscopy studies in patients with schizophrenia attending to auditory hallucinations. The aim of the present study is to explore metabolic Magnetic Resonance Spectroscopy (MRS) ratio differences in the thalamus between schizophrenic patients with and without auditory hallucinations and control subjects. Methods MRS studies (MRI 1.5 T unit) were performed in 49 patients with schizophrenia (30 with auditory hallucinations and 19 without au…

AdultMalePsychosismedicine.medical_specialtyMagnetic Resonance SpectroscopyHallucinationsThalamusAudiologyFunctional LateralityCholineThalamusBrief Psychiatric Rating ScalemedicineBrief Psychiatric Rating ScaleHumansBiological PsychiatryAspartic AcidAuditory hallucinationmedicine.diagnostic_testPositive and Negative Syndrome ScaleMagnetic resonance imagingCreatinemedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthSchizophreniaSchizophreniaAge of onsetmedicine.symptomPsychologyNeuroscienceSchizophrenia Research
researchProduct

Risperidone Versus Haloperidol and Amitriptyline in the Treatment of Patients With a Combined Psychotic and Depressive Syndrome

1998

In a multicenter, double-blind, parallel group trial, the efficacy of risperidone (RIS) was compared with a combination of haloperidol and amitriptyline (HAL/AMI) over 6 weeks in patients with coexisting psychotic and depressive symptoms with either a schizoaffective disorder, depressive type, a major depression with psychotic features, or a nonresidual schizophrenia with major depressive symptoms according to DSM-III-R criteria. A total of 123 patients (62 RIS; 61 HAL/AMI) were included; the mean daily dosage at endpoint was 6.9 mg RIS versus 9 mg HAL combined with 180 mg AMI. Efficacy results for those 98 patients (47 RIS; 51 HAL/AMI) who completed at least 3 weeks of double-blind treatme…

AdultMalemedicine.medical_specialtyAdolescentAmitriptylineSchizoaffective disorderAntidepressive Agents Tricycliclaw.inventionDouble-Blind MethodExtrapyramidal symptomsRandomized controlled triallawInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmitriptylinePsychiatryAgedPsychiatric Status Rating ScalesDepressive DisorderRisperidoneMiddle AgedRisperidonemedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaHaloperidolFemalemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Dose-Related Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of Schizophrenia

2002

The present analysis investigated symptom-specific dose-response relationships of the atypical antipsychotic amisulpride (AMI) in schizophrenic patients. The effects of different AMI doses on five different symptom dimensions of the Brief Psychiatric Rating Scale (BPRS) were analyzed. Results on global efficacy and safety parameters have been previously published. Four AMI doses (100 mg/day [AMI100], 400 mg/day [AMI400], 800 mg/day [AMI800], 1200 mg/day) were compared with 16 mg haloperidol (HAL16) in a multicenter, double-blind, randomized, parallel-group, 4-week trial. A total of 319 patients with acute exacerbation of schizophrenia (DSM-III-R) were included. AMI100 was compared with the …

AdultMalemedicine.medical_specialtyAdolescentExacerbationmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmisulpridePsychiatryAntipsychoticPsychiatric Status Rating ScalesDose-Response Relationship DrugDopamine antagonistMiddle AgedPsychiatry and Mental healthTreatment OutcomeSchizophreniaHaloperidolAnxietyFemaleSchizophrenic PsychologyAmisulprideSulpiridemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophreni…

2002

While many acutely ill schizophrenic patients suffer from depressive symptoms, most studies on the efficacy of antipsychotic drugs focus on positive and negative symptoms. Dimensional models of schizophrenic symptoms, based on confirmatory factor analysis (CFA) using structural equation modelling, offer a methodological alternative to compare antipsychotics on empirically justified latent factors. The present report is a refined analysis of a published double-blind study on the D 2 /D 3 -selective antagonist amisulpride (ASP) versus the mixed D 1-5 /5-HT 2 antagonist flupentixol (FPX). CFA was applied to Brief Psychiatric Rating Scale, Scale for the Assessment of Negative Symptoms, Bech-Raf…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentDouble-Blind MethodBrief Psychiatric Rating ScalemedicineHumansPharmacology (medical)AmisulprideAntipsychoticPsychiatryScale for the Assessment of Negative SymptomsAgedMiddle Agedmedicine.diseaseConfirmatory factor analysisFlupentixolFlupenthixolPsychiatry and Mental healthAffectPsychotropic drugSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAmisulprideSulpiridePsychologyFactor Analysis Statisticalmedicine.drugAntipsychotic AgentsInternational clinical psychopharmacology
researchProduct

Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.

1989

We determined brain density and ventricular measurements with computerized tomography (CT) in 33 depressed patients and compared the results with basal plasma cortisol and its suppressibility by dexamethasone. Mean plasma cortisol was positively related to elevated ventricular brain ratio (VBR). No association could be found between dexamethasone suppression test (DST) status and VBR or any other CT parameter. Elevated plasma cortisol levels and increased VBRs were positively correlated with total scores on the Brief Psychiatric Rating Scale, the Global Assessment Scale and the Bech-Rafaelsen Melancholia Scale, but they were not significantly correlated with total score on the Hamilton Anxi…

AdultMalemedicine.medical_specialtyHydrocortisoneEndocrinology Diabetes and MetabolismDexamethasoneCerebral VentriclesBasal (phylogenetics)EndocrinologyInternal medicineMelancholiaBrief Psychiatric Rating ScalemedicineHumansBiological PsychiatryDexamethasoneDepression (differential diagnoses)HydrocortisonePsychiatric Status Rating ScalesDepressive DisorderEndocrine and Autonomic SystemsBrainMiddle AgedVentricular-brain ratioPsychiatry and Mental healthEndocrinologyDexamethasone suppression testFemalemedicine.symptomPsychologyTomography X-Ray Computedmedicine.drugPsychoneuroendocrinology
researchProduct

Light exposure patterns in schizophrenia

1992

Spontaneous light exposure patterns were studied in 10 chronic schizophrenic patients. Half of our schizophrenic patients exposed themselves to bright light exceeding ordinary indoor illumination. There was a significant positive correlation between the percentage of exposure to bright light and the Brief Psychiatric Rating Scale subscore anergia and a significant negative correlation with depression.

AdultMalemedicine.medical_specialtyPsychosisAnxietyAudiologySocial EnvironmentArousalSchizophrenic PsychologyBrief Psychiatric Rating ScalemedicineHumansPsychiatryLightingDepression (differential diagnoses)AgedLight exposurePsychiatric Status Rating ScalesDepressionMiddle Agedmedicine.diseaseHospitalizationPsychiatry and Mental healthSchizophreniaSchizophreniaSchizophrenic PsychologyArousalPsychologyBright lightActa Psychiatrica Scandinavica
researchProduct

Mood profile of an America's Cup team: relationship with muscle damage and injuries.

2010

Purpose: To describe the mood profile of an America’s Cup sailing team during competition and to evaluate the influence of previous injuries occurrence and intensity of physical work on the boat upon mood state. Relationships between mood domains and metabolic markers of muscle damage were also investigated. Methods: A descriptive study was conducted on an America’s Cup yachting race crew comprising 21 male sailors (mean T SD; age = 27.6 T 8.5 yr, weight = 89.3 T 24.9 kg, BMI = 26.5 T 6.9 kgImj2). All measurements were collected during the Louis Vuitton Cup 2007 in Valencia, Spain. The POMS test and creatine kinase (CK) serum activity were measured and correlated. Sailors were grouped accor…

AdultMalemedicine.medical_specialtyWorkEpidemiologyCumulative Trauma Disordersmedia_common.quotation_subjectPhysical ExertionPoison controlPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseMuscle damageAngerAngerYoung AdultInjury preventionmedicineBrief Psychiatric Rating ScaleHumansOrthopedics and Sports MedicineConfusionMuscle SkeletalExerciseDepression (differential diagnoses)Shipsmedia_commonPsychology in Sportbiologybusiness.industryDepressionMood DisordersPreventionMoodMuscle FatiguePhysical therapybiology.proteinCreatine kinasebusinessSportsMedicine and science in sports and exercise
researchProduct

Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophreniaspectrum disorders: Findings f…

2020

This study, based on the 'Servizi Territoriali Associati per la Ricerca' (STAR) Network Depot Study nationwide baseline data, explored whether individual symptoms severity and clusters might influence the prescription of paliperidone palmitate 1-month (PP1M) vs. aripiprazole monohydrate. The Brief Psychiatric Rating Scale (BPRS) was used to assess psychopathology and relevant symptoms clusters. Drug Attitude Inventory, 10 items, was used to test attitude towards medications. Adherence to treatments was rated according to the Kemp seven-point scale. We assessed for eligibility 451 individuals and, among them, we included 195 subjects (n = 117 who started PPM1 and n = 78 aripiprazole monohydr…

Aripiprazole monohydrate; Long-acting injectable antipsychotics; Paliperidone palmitate; Schizophrenia; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Knowledge Attitudes Practice; Humans; Male; Medication Adherence; Paliperidone Palmitate; Practice Patterns Physicians'; Schizophrenia; Schizophrenic Psychology; Young AdultAdultMaleLong-acting injectable antipsychoticmedicine.medical_specialtyHealth Knowledge Attitudes Practicemedicine.medical_treatmentAripiprazole monohydrate Long-acting injectable antipsychotics Paliperidone palmitate SchizophreniaAripiprazolePractice PatternsLong-acting injectable antipsychoticsMedication Adherence03 medical and health sciencesYoung Adult0302 clinical medicineAripiprazole monohydrate; Long-acting injectable antipsychotics; Paliperidone palmitate; SchizophreniaInternal medicineBrief Psychiatric Rating ScalemedicineHumansPharmacology (medical)Practice Patterns Physicians'AntipsychoticSettore MED/25 - PsichiatriaPaliperidone PalmitatePaliperidone palmitatePracticePhysicians'business.industryHealth KnowledgeAripiprazole monohydratemedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaAttitudesPropensity score matchingSchizophreniaObservational studyAripiprazoleFemaleSchizophrenic Psychologybusiness030217 neurology & neurosurgerymedicine.drugPsychopathologyAntipsychotic Agents
researchProduct